DISEASE INDICATIONS: Psoriasis
MANUFACTURER: Boehringer Ingelheim
USAGE: Intravenous
MEDICINE APPROVED BY:
European Medical Agency (EMA)
Food and Drug Administration (FDA)
Spevigo (spesolimab-sbzo) is a prescription medication used to treat generalized pustular psoriasis (GPP) flares in adults. GPP is a rare autoinflammatory skin disease that can cause painful pustules (blisters) to form all over the body. Spevigo is the first FDA-approved treatment for GPP flares.
DISEASE INDICATIONS: Spinal Muscular Atrophy
MANUFACTURER: Biogen Idec Ltd
USAGE: Intrathecal Injection
MEDICINE APPROVED BY:
European Medical Agency (EMA)
Food and Drug Administration (FDA)
Health Canada
Therapeutic Goods Administration (TGA)
Medsafe (NZ)
Spinraza, also known by its generic name Nusinersen, is a groundbreaking medication that has transformed the landscape of treatment for Spinal Muscular Atrophy (SMA), a rare genetic disorder characterized by the progressive degeneration of motor neurons in the spinal cord.
CHARACTERISTICS
ACTIVE HALF-LIFE 8 HOURS
CLASSIFICATION ANABOLIC STEROID
DOSAGE 50-100 MG/DAY
ACNE YES
WATER RETENTION NO
HBR PERHAPS
HEPATOTOXICITY HIGH
AROMATIZATION NO
ACTIVE SUBSTANCE STANOZOLOL
FORM 100 TABLETS X 10 MG
MANUFACTURER HILMA BIOCARE
CHARACTERISTICS
ACTIVE HALF-LIFE 1 DAY
CLASSIFICATION ANABOLIC STEROID
DOSAGE MEN 300-400 MG/WEEK
ACNE YES
WATER RETENTION NO
HBR NO
HEPATOTOXICITY YES
AROMATIZATION NO
ACTIVE SUBSTANCE STANOZOLOL
FORM 10 ML X 50 MG/ML
MANUFACTURER HILMA BIOCARE
Stelara, known by its generic name Ustekinumab, is a prescription medication used in the treatment of certain autoimmune diseases, primarily plaque psoriasis, psoriatic arthritis, and Crohn's disease.
CHARACTERISTICS
ACTIVE HALF-LIFE 3-6 HOURS
CLASSIFICATION SSRI & PDE5 INHIBITOR
DOSAGE MEN 40-80 MG/DAY
ACNE NO
WATER RETENTION NO
HBR PERHAPS
HEPATOTOXICITY NO
AROMATIZATION NO
ACTIVE SUBSTANCE DAPOXETINE, VARDENAFIL
FORM 10 PILLS X 80 MG
MANUFACTURER CENTURION LABORATORIES
CHARACTERISTICS
ACTIVE HALF-LIFE 16 DAYS
CLASSIFICATION ANABOLIC STEROID
DOSAGE 500-700 MG/WEEK
HEPATOTOXICITY LOW
AROMATIZATION MEDIUM
ACTIVE SUBSTANCE DROSTANOLONE ENANTHATE, TESTOSTERONE ENANTHATE, TRENBOLONE ENANTHATE
FORM 10 ML X 400 MG/ML
MANUFACTURER SIS LABS
